Sort   by:  
 Page size 
UnknownThe Molecular and Function Characterization of Porcine MID2.
Not available
S-EPMC10526110 | biostudies-literature
UnknownDevelopment and validation of a risk score for predicting 30-day mortality in patients with ST elevation myocardial infarction.
Not available
S-EPMC11909249 | biostudies-literature
UnknownAnalysis of Water Adsorption Capacity, Thermal Behavior, Antioxidant Activity, and Smoke Volume by Polyol Ester in Reconstituted Tobacco
Not available
S-EPMC11541444 | biostudies-literature
UnknownIdentification of a novel human papillomavirus by metagenomic analysis of vaginal swab samples from pregnant women.
Not available
S-EPMC4943014 | biostudies-literature
UnknownA chromosome-level reference genome facilitates the discovery of clubroot-resistant gene <i>Crr5</i> in Chinese cabbage.
Not available
S-EPMC11879649 | biostudies-literature
UnknownGenome assembly of pomegranate highlights structural variations driving population differentiation and key loci underpinning cold adaption.
Not available
S-EPMC11979328 | biostudies-literature
UnknownDevelopment of a leaf metabolite-based intact sample distinguishing algorithm for the three varieties of Panax Vietnamensis.
Not available
S-EPMC11885644 | biostudies-literature
ProteomicsMetabolic-engineered probiotic- OMVs as nanovaccine mediating sequential immunomodulation for chronic bone infection immunotherapy
Lei et al. screen out Lactococcus lactis OMVs (Lac-OMVs) and develop metabolic-engineered NAD+-Lac-OMVs nanovaccine with potent tissue repair therapeutic effect. NAD+-Lac-OMVs sequentially activate dendritic cells by membrane component and reprogram inflammatory macrophages for anti-inflammation and...
ORGANISM(S): Mus Musculus 
2026-03-23 | PXD076052 |
UnknownGradient perfusion features can effectively identify sentinel lymph node metastasis in early breast cancer.
Not available
S-EPMC12771732 | biostudies-literature
MetabolomicsMethionine Intervention Induces PD-L1 Expression to Enhance the Immune Checkpoint Therapy Response in MTAP-deleted Osteosarcoma
Osteosarcoma (OS), a malignant bone tumor with limited treatment options, exhibits low sensitivity to immune checkpoint therapy (ICT). Through genomics and transcriptomics analyses, we have identified a subgroup of OS with methylthioadenosine phosphorylase (MTAP) deletion, which contributes to ICT r...
2026-06-09 | MTBLS11985 | MetaboLights
Sort   by:  
 Page size